Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1100

1.

Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK, Seber A, Saber W, Kharfan-Dabaja MA, Rasheed W, Okamoto S, Khera N, Wood WA, Koh MBC, Greinix H, Kodera Y, Szer J, Horowitz MM, Weisdorf D, Aljurf M.

Bone Marrow Transplant. 2019 Oct 15. doi: 10.1038/s41409-019-0714-y. [Epub ahead of print]

PMID:
31616063
2.

Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Omae K, Kodera Y.

BMC Surg. 2019 Oct 15;19(1):143. doi: 10.1186/s12893-019-0617-2.

3.

Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Omae K, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07914-7. [Epub ahead of print]

PMID:
31605344
4.

Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer.

Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32705. [Epub ahead of print]

PMID:
31597194
5.

Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).

Misawa K, Mochizuki Y, Sakai M, Teramoto H, Morimoto D, Nakayama H, Tanaka N, Matsui T, Ito Y, Ito S, Tanaka K, Uemura K, Morita S, Kodera Y; Chubu Clinical Oncology Group.

Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303. [Epub ahead of print]

PMID:
31573086
6.

Tumor size  ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset.

Tsutsuyama M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Sep 24. doi: 10.1007/s00268-019-05198-2. [Epub ahead of print]

PMID:
31552460
7.

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).

Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y.

Int J Clin Oncol. 2019 Sep 21. doi: 10.1007/s10147-019-01546-3. [Epub ahead of print]

PMID:
31542847
8.

Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice.

Ito A, Nakanishi H, Yoshimura M, Ito S, Sakao Y, Kodera Y, Yatabe Y, Kaneda N.

Anticancer Res. 2019 Sep;39(9):4711-4720. doi: 10.21873/anticanres.13653.

PMID:
31519570
9.

Molecular form and concentration of serum α2-macroglobulin in diabetes.

Yoshino S, Fujimoto K, Takada T, Kawamura S, Ogawa J, Kamata Y, Kodera Y, Shichiri M.

Sci Rep. 2019 Sep 10;9(1):12927. doi: 10.1038/s41598-019-49144-7.

10.

Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset.

Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Ann Surg Oncol. 2019 Sep 6. doi: 10.1245/s10434-019-07781-2. [Epub ahead of print]

PMID:
31493125
11.

Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.

Kobayashi D, Ishigami H, Kanda M, Tanaka C, Yamaguchi H, Kitayama J, Kodera Y.

Oncology. 2019 Sep 5:1-5. doi: 10.1159/000502484. [Epub ahead of print]

PMID:
31487733
12.

Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK, Seber A, Saber W, Kharfan-Dabaja MA, Rasheed W, Okamoto S, Khera N, Wood WA, Koh MBC, Greinix H, Kodera Y, Szer J, Horowitz MM, Weisdorf D, Aljurf M.

Bone Marrow Transplant. 2019 Sep 4. doi: 10.1038/s41409-019-0658-2. [Epub ahead of print] Review. Erratum in: Bone Marrow Transplant. 2019 Oct 15;:.

PMID:
31484992
13.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Ali Hamidieh A, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitsky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D.

Hematol Oncol Stem Cell Ther. 2019 Aug 20. pii: S1658-3876(19)30055-X. doi: 10.1016/j.hemonc.2019.08.002. [Epub ahead of print]

14.

Ultrafast laser welding of ceramics.

Penilla EH, Devia-Cruz LF, Wieg AT, Martinez-Torres P, Cuando-Espitia N, Sellappan P, Kodera Y, Aguilar G, Garay JE.

Science. 2019 Aug 23;365(6455):803-808. doi: 10.1126/science.aaw6699.

PMID:
31439794
15.

Incorporating molecular biomarkers into clinical practice for gastric cancer.

Nakamura S, Kanda M, Kodera Y.

Expert Rev Anticancer Ther. 2019 Sep;19(9):757-771. doi: 10.1080/14737140.2019.1659136. Epub 2019 Aug 26.

PMID:
31437076
16.

Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.

Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y.

Gastric Cancer. 2019 Aug 3. doi: 10.1007/s10120-019-00995-z. [Epub ahead of print]

PMID:
31377880
17.

Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A.

Clin Cancer Res. 2019 Oct 15;25(20):6170-6179. doi: 10.1158/1078-0432.CCR-19-0318. Epub 2019 Jul 29.

PMID:
31358543
18.

Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer.

Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Cancer Med. 2019 Sep;8(11):5194-5201. doi: 10.1002/cam4.2439. Epub 2019 Jul 29.

19.

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.

Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T.

Int J Clin Oncol. 2019 Jul 8. doi: 10.1007/s10147-019-01498-8. [Epub ahead of print]

PMID:
31286289
20.

Splenectomy in living donor liver transplantation and risk factors of portal vein thrombosis.

Kurata N, Ogura Y, Ogiso S, Onishi Y, Kamei H, Kodera Y.

Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):337-342. doi: 10.1016/j.hbpd.2019.06.011. Epub 2019 Jun 26.

PMID:
31278029
21.

Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma.

Sonohara F, Yamada S, Tanaka N, Tashiro M, Sunagawa Y, Morimoto D, Tanaka H, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Hepatol Res. 2019 Jul 1. doi: 10.1111/hepr.13400. [Epub ahead of print]

PMID:
31260575
22.

Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.

Umeda S, Kanda M, Kodera Y.

Expert Rev Mol Diagn. 2019 Aug;19(8):725-738. doi: 10.1080/14737159.2019.1638254. Epub 2019 Jul 3.

PMID:
31248309
23.

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy.

Miwa T, Kanda M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

J Gastric Cancer. 2019 Jun;19(2):183-192. doi: 10.5230/jgc.2019.19.e15. Epub 2019 Apr 22.

24.

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.

Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y.

Nagoya J Med Sci. 2019 May;81(2):233-239. doi: 10.18999/nagjms.81.2.233.

25.

Long-lasting discussion: Adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer.

Nakanishi K, Kanda M, Kodera Y.

World J Gastroenterol. 2019 Jun 14;25(22):2743-2751. doi: 10.3748/wjg.v25.i22.2743. Review.

26.

Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Omae K, Kodera Y.

Ann Surg Oncol. 2019 Oct;26(11):3718-3726. doi: 10.1245/s10434-019-07512-7. Epub 2019 Jun 13.

PMID:
31197518
27.

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.

Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H.

Mol Ther Oncolytics. 2019 May 13;13:107-115. doi: 10.1016/j.omto.2019.04.004. eCollection 2019 Jun 28.

28.

Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Harif M, Weisdorf D, Novitzky N, Szer J, Mahmal L, Benakli M, Ben Othman T, Bazuaye N, McGrath E, Eldridge PW, Torjemane L, Madani A, Ahmed Nacer R, Belkhedim R, Rasheed W, Ahmed SO, Kodera Y, Aljurf M, Niederwieser DW, Quessar A.

Hematol Oncol Stem Cell Ther. 2019 Jun 4. pii: S1658-3876(19)30048-2. doi: 10.1016/j.hemonc.2019.05.003. [Epub ahead of print]

29.

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens.

Sonohara F, Yamada S, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Eur J Surg Oncol. 2019 Oct;45(10):1895-1900. doi: 10.1016/j.ejso.2019.05.019. Epub 2019 May 22.

PMID:
31147087
30.

Preoperative six-minute walk distance as a predictor of postoperative complication in patients with esophageal cancer.

Inoue T, Ito S, Kanda M, Niwa Y, Nagaya M, Nishida Y, Hasegawa Y, Koike M, Kodera Y.

Dis Esophagus. 2019 May 20. pii: doz050. doi: 10.1093/dote/doz050. [Epub ahead of print]

PMID:
31111872
31.

A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey.

Poudel S, Hirano S, Kurashima Y, Stefanidis D, Akiyama H, Eguchi S, Fukui T, Hagiwara M, Hashimoto D, Hida K, Izaki T, Iwase H, Kawamoto S, Otomo Y, Nagai E, Saito M, Takami H, Takeda Y, Toi M, Yamaue H, Yoshida M, Yoshida S, Kodera Y.

Surg Today. 2019 Oct;49(10):870-876. doi: 10.1007/s00595-019-01819-4. Epub 2019 May 17.

PMID:
31102022
32.

Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015.

Iida M, Kodera Y, Dodds A, Ho AYL, Nivison-Smith I, Akter MR, Wu T, Lie AKW, Ghavamzadeh A, Kang HJ, Ong TC, Gyi AA, Farzana T, Baylon H, Gooneratne L, Tang JL, Bunworasate U, Huynh VM, Srivastava A, Okamoto S, Atsuta Y; Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT).

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0554-9. [Epub ahead of print]

PMID:
31089289
33.

A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0542-0. [Epub ahead of print] No abstract available.

PMID:
31089273
34.

Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study.

Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y.

Asian J Endosc Surg. 2019 May 8. doi: 10.1111/ases.12710. [Epub ahead of print]

PMID:
31070004
35.

Identification of plasma binding proteins for glucose-dependent insulinotropic polypeptide.

Hoshiyama A, Fujimoto K, Konno R, Sasaki S, Momozono A, Kodera Y, Shichiri M.

Endocr J. 2019 Jul 28;66(7):621-628. doi: 10.1507/endocrj.EJ18-0472. Epub 2019 Apr 26.

36.

The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.

Nakanishi K, Kanda M, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Kodera Y.

Gastric Cancer. 2019 May 4. doi: 10.1007/s10120-019-00967-3. [Epub ahead of print]

PMID:
31055693
37.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30235-6. doi: 10.1016/j.bbmt.2019.04.012. [Epub ahead of print] Review.

PMID:
31002990
38.

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.

Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Gastrointest Oncol. 2019 Jan 15;11(1):17-27. doi: 10.4251/wjgo.v11.i1.17.

39.

Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset.

Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Apr 6. doi: 10.1007/s10120-019-00961-9. [Epub ahead of print]

PMID:
30955110
40.

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.

Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M.

J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29.

PMID:
30925125
41.

Effects of duration of initial treatment on postoperative complications in pancreatic cancer.

Yamada S, Takami H, Sonohara F, Hayashi M, Fujii T, Kodera Y.

J Hepatobiliary Pancreat Sci. 2019 Jun;26(6):235-241. doi: 10.1002/jhbp.622. Epub 2019 Apr 9.

PMID:
30919565
42.

Detection of a novel tick-borne flavivirus and its serological surveillance.

Shimoda H, Hayasaka D, Yoshii K, Yokoyama M, Suzuki K, Kodera Y, Takeda T, Mizuno J, Noguchi K, Yonemitsu K, Minami S, Kuwata R, Takano A, Maeda K.

Ticks Tick Borne Dis. 2019 Jun;10(4):742-748. doi: 10.1016/j.ttbdis.2019.03.006. Epub 2019 Mar 16.

PMID:
30902589
43.

Positive rates of anti-acari-borne disease antibodies of rural inhabitants in Japan.

Takeda T, Fujita H, Iwasaki M, Kasai M, Tatori N, Endo T, Kodera Y, Yamabata N.

J Vet Med Sci. 2019 May 31;81(5):758-763. doi: 10.1292/jvms.18-0572. Epub 2019 Mar 20.

44.

The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.

Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Dig Surg. 2019 Mar 6:1-10. doi: 10.1159/000497454. [Epub ahead of print]

PMID:
30840952
45.

Gain in polycrystalline Nd-doped alumina: leveraging length scales to create a new class of high-energy, short pulse, tunable laser materials.

Penilla EH, Devia-Cruz LF, Duarte MA, Hardin CL, Kodera Y, Garay JE.

Light Sci Appl. 2018 Jul 4;7:33. doi: 10.1038/s41377-018-0023-z. eCollection 2018.

46.

Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.

Tsutsuyama M, Nakanishi H, Yoshimura M, Oshiro T, Kinoshita T, Komori K, Shimizu Y, Ichinosawa Y, Kinuta S, Wajima K, Sakakibara Y, Yatabe Y, Ito S, Kodera Y.

PLoS One. 2019 Feb 27;14(2):e0212221. doi: 10.1371/journal.pone.0212221. eCollection 2019.

47.

"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".

Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N, Shaw BE, Greinix H, Kharfan-Dabaja MA, Foeken L, Seber A, Ahmed S, El-Jawahri A, Al-Awwami M, Atsuta Y, Pasquini M, Hanbali A, Alzahrani H, Okamoto S, Gluckman E, Mohty M, Kodera Y, Horowitz M, Niederwieser D, El Fakih R.

Bone Marrow Transplant. 2019 Aug;54(8):1179-1188. doi: 10.1038/s41409-019-0476-6. Epub 2019 Feb 18. Review.

48.

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.

Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y.

HPB (Oxford). 2019 Sep;21(9):1211-1218. doi: 10.1016/j.hpb.2019.01.012. Epub 2019 Feb 14.

PMID:
30773450
49.

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.

Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, Kodera Y, Wang X, Baba H, Goel A.

EBioMedicine. 2019 Mar;41:268-275. doi: 10.1016/j.ebiom.2019.01.057. Epub 2019 Feb 13.

50.

Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis.

Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Aug;43(8):2016-2024. doi: 10.1007/s00268-019-04942-y.

PMID:
30737551

Supplemental Content

Loading ...
Support Center